Pale Fire Capital SE’s OnKure Therapeutics OKUR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,010
Closed -$48.2K 80
2023
Q4
$48.2K Buy
3,010
+1,525
+103% +$95K 0.01% 72
2023
Q3
$113K Buy
+1,485
New +$101K 0.01% 45

Other funds holding OKUR

Pale Fire Capital SE's OKUR Position: Q1 2024 in Review

Pale Fire Capital SE sold out of OnKure Therapeutics (OKUR) in Q1 2024, closing a stake of 3,010 shares — an estimated $48.2K sold.

Pale Fire Capital SE first reported a position in OKUR in Q3 2023 and held it in 2 quarters. The position peaked at $113K in Q3 2023. 61 funds tracked by Wall St. Rank hold OKUR as of Q1 2024.

  • Pale Fire Capital SE reported no remaining OnKure Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Pale Fire Capital SE sold 3,010 OnKure Therapeutics shares in Q1 2024, an estimated $48.2K.
  • Pale Fire Capital SE first reported a position in OnKure Therapeutics in Q3 2023 and held it in 2 quarters.
  • Pale Fire Capital SE's OnKure Therapeutics position peaked at $113K in Q3 2023.
  • 61 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q1 2024.

Based on Pale Fire Capital SE's 13F filing for Q1 2024, filed 14 May 2024.